TrialThe Lancet. Infectious diseases2023

Efficacy against pneumococcal carriage and the immunogenicity of reduced-dose (0 + 1 and 1 + 1) PCV10 and PCV13 schedules in Ho Chi Minh City, Viet Nam: a parallel, single-blind, randomised controlled trial.

Beth Temple et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.